Discovery of a Novel Trifunctional Inhibitor for B Cell Driven Diseases
Time: 11:30 am
day: Conference Day Two
Details:
• Trifunctional target inhibition to address the root causes of B cell-driven diseases
• Engineering best-in-class pH-dependent binding to FcRn for clearance of IgG and extended 1/2-life
